[1]
Devi, W.R., Prenggono, M.D., AP, P. and B, I. 2020. Differences of Bone Marrow Features and BCR-ABL Variants in Chronic Granulocytic Leukemia Post Tyrosine Kinase Inhibitor Therapy. INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY. 26, 2 (Mar. 2020), 217–222. DOI:https://doi.org/10.24293/ijcpml.v26i2.1457.